Effectiveness, immunogenicity, and safety of the quadrivalent HPV vaccine in women and men aged 27-45 years
Among women aged 27-45 years, the quadrivalent human papillomavirus (qHPV; HPV6/11/16/18) vaccine was generally well tolerated, efficacious, and immunogenic in the placebo-controlled FUTURE III study (NCT00090220; n = 3253). The qHPV vaccine was also generally well tolerated and highly immunogenic i...
Saved in:
Main Authors: | , , , , , , , , , , , , , , , , , |
---|---|
格式: | 图书 |
出版: |
Taylor & Francis Group,
2022-11-01T00:00:00Z.
|
主题: | |
在线阅读: | Connect to this object online. |
标签: |
添加标签
没有标签, 成为第一个标记此记录!
|
因特网
Connect to this object online.3rd Floor Main Library
索引号: |
A1234.567 |
---|---|
复印件 1 | 可用 |